The landscape of managing diabetes is evolving with the emergence of skin-applied GLP-1 therapy. These convenient delivery systems offer a possibly more comfortable alternative to injections for individuals living with diabetes mellitus type 2 . Such a system deliver glucagon-like peptide-1 directly through the dermis , circumventing the requiremen